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intense treatment. These feelings are compounded when they
develop complications such as chronic graft-versus-host disease
(cGVHD). The Plunge for Patients, which was originally started as
a fund raising event, has now become a support network for
patients and families after BMT. The weekend event includes
beach runs, ocean swims, and a patient and family beach party.
Patients and families who attend the Plunge for Patients are able to
meet others who share similar experiences, treatments, and com-
plications. Caregivers and family members are able to share hints
and gain support. Families who have lost a family member also
attend the event, often gaining closure, and later are able to
celebrate the life of their loved one by sharing pictures and their
life stories. Many patients and family members meet throughout
the year to help plan for the event and assist with fund raising.
Most patients and/or families write a short story about their expe-
riences and share it the athletes. The patients, families, and athletes
meet each other after the races. Many teenagers who have attended
the races have chosen careers in the health care ﬁeld after meeting
the patients and families and reading their inspirational stories.
The Plunge for Patients is open to all patients who have received
a transplant at any center around the world. This is particularly
valuable to patients with cGVHD, where the physical manifesta-
tions of the disease are distressing to the patient. Because of the
large number of patients with chronic GVHD attending the event,
many patients are able to ﬁnd “buddies” who are a similar age and
sex to help them deal with the ongoing struggles of this debilitating
illness.
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BE IMPRESSED WITH PRES
Mishaw, K., de Lima, M., Giralt, S., Hosing, C. University of TX MD
Anderson Cancer Center, Houston, TX
Posterior reversible encephalopathy syndrome (PRES) has re-
cently been described post allogeneic hematopoietic stem cell
transplant in patients receiving Tacrolimus.
The neurotoxocity associated with calcineurin inhibitors such as
Tacrolimus are usually limited to mild symptoms such as headache,
tremors, parethesias, insomnia, photophobia and mood distur-
bances. A more severe neurotoxocity has been seen in selected
patients and includes altered mental status, cognitive deﬁcits, sei-
zures, visual disturbances and coma. This clinical picture along
with distinct radiologic ﬁndings of edema involving the white
matter in the posterior portions of the cerebral hemispheres re-
sulted in the terminology, posterior reversible encephalopathy syn-
drome.
PRES is associated with various etiologies, one of which is use of
immunosuppression such as Tacrolimus and Cyclosporin. The
pathophysiology with immunosuppressive agents is not well delin-
eated but is thought to be due to an acute episode of vasogenic
edema in the vertebral white matter with a predeliction for the
posterior temporal, parietal and occipital regions. The extracellular
edema is attributed to autoregulatory dysfunction in the posterior
circulation and with a transient breakdown of the blood brain
barrier with a leakage of protein/ﬂuids causing the neuronal injury.
Since PRES is progressive but potentially reversible, early detec-
tion and intervention is paramount. Nurses need to be aware of this
rare syndrome and knowledgeable of signs/symptoms of the sub-
acute prodromal period. Early identiﬁcation of these s/s would
provide the medical team an opportunity to initiate treatment early
thereby minimizing morbidity. Nurses also need to be knowledge-
able of the medical treatment and nursing management required by
patients experiencing this syndrome.
This presentation will utilize 3 case scenarios to review the
clinical presentation, pathophysiology, known risk factors, differ-
ential diagnosis, diagnostic imaging, medical treatment and nurs-
ing management of patients experiencing PRES.
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WE ARE KINDER TO OUR PATIENTS THAN WE ARE TO EACH OTHER:
HOW CAN WE ACT THE SAME TOWARD EVERYONE?
Sorensen, S.H., Tran, H.T., Canales, L., Valdez, M., Holmes, T. M D
Anderson Cancer Center, Houston, TX
We were recently asked to participate in an Institutional wide
Employee Opinion Survey (EOS). One of the most interesting
ﬁndings was that approximately 60 % of the employees in our
institution thought we were kinder to our patients than we were to
each other. We were challenged to improve this rating.
The Apheresis group picked an EOS team to lead this challenge.
The members surveyed the group to ﬁnd the 2 areas they wanted
to improve the most. Based on the outcomes of this survey, aim
statements were developed.
The ﬁrst identiﬁed questioned our behaviors and actions toward
our co-workers regarding consistency with our Core Values of
“Caring-by our words and actions, we create a caring environment
for everyone.” The second questioned whether employees at the
institution are able to contribute to their fullest potential regardless
of their age, race, ethnic background, gender, religion or disability
statue.
To meet the above stated objectives, the plan was to develop a
“voice box” for the employees to share their thoughts on the
following: What went well this week?, What didn’t go well?, and
suggestions for improvement.
The EOS team gathers these responses and lists them for the
team to talk about at a lunch meeting every other week.
Thus far, we have discussed the following with positive results:
Need for “report” when taking over procedures for lunch or at the
end of the day, “Ofﬁcially” agreed upon times for lunch, Stocking
each area daily, Completing documentation, Run times for proce-
dures and Standard Operating Procedures (SOP) development.
The staff have been encouraged by these discussions. They have
commented on how potentially explosive issues have been resolved
as a group with each member respecting the others opinion while
maintaining a democratic approach.
The above results were presented to the Chief Operating Ofﬁc-
ers of the Institution to rave reviews. The next step is to incorpo-
rate the best ideas from each unit and apply them at an institutional
level.
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IMPROVING CLINICAL AND OPERATIONAL OUTCOMES THROUGH A
SHARED GOVERNANCE PRACTICE COUNCIL STRUCTURE
Johnston, P., Blackburn, R., Causton, C., Davis, L., Dela Cruz, B.,
Jewell, J. UT MD Anderson Cancer Center, Houston, TX
Nursing in today’s ever-changing, complex healthcare environ-
ment encounters multiple challenges, including: role expansion,
cost-containment efforts, and the healthcare system’s redesign to
prepare for forecasted issues facing the profession. While these
challenges can be overwhelming, nurses no longer accept the
assignment of tasks as their practice goal outcomes. Today’s nurses
seek opportunities to provide comprehensive professional care
through a system that supports autonomy and staff input regarding
decision-making. Traditional models of administrative structures
are presently in a state of ﬂux as organizational structures ﬂatten
and team structures increase. Creating environments of teamwork
and creativity are essential for achieving desired improvement in
clinical and operational outcomes. Building upon the nursing di-
vision’s shared governance practice council structure, the inpatient
BMT unit replicated the majority of practice councils at the unit
level. These included a: Clinical Practice Council, Research Coun-
cil, Education Council, Quality Improvement Council, and Coor-
dinating Council. Annually each council is responsible for estab-
lishing goals. Active participation is expected by the nursing staff in
achievement of a component of their professional development
model evaluation. Improved outcomes achieved this past year in-
cluded: preparation for the Foundation for the Accreditation of
Cellular Therapy (FACT) survey, development of BMT nursing
standards of care formatted to meet FACT accreditation guide-
lines, a BMT patient education manual, monitoring nursing doc-
umentation audits, redesigning the measurement of patient satis-
faction with nursing care, developing and instituting this year’s
unit based competencies, and a staff recognition program. The
outcomes of shared decision making have promoted effective qual-
ity patient care, accountability, staff and leadership satisfaction and
professional role development demonstrating the mission, vision,
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and core values of our organization and is viewed as a positive force
on the unit.
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ABC’S OF ABO–A REFRESHER FOR BLOOD AND MARROW TRANSPLANT
NURSES
Meyers, A.L. University of Texas MD Anderson Cancer Center, Hous-
ton, TX
Blood and Marrow Transplant (BMT) nurses must posses a vast
knowledge of many complicated nursing assessment skills. Sup-
portive measures that the team must institute to carry a patient
safely through this treatment regimen, include administration of
broad-spectrum antibiotics and blood products. Of the many re-
sponsibilities for BMT nurses blood administration is a major
psychomotor skill that is performed daily and often perceived as an
easy skill when in actuality it can be a very involved process. BMT
patients need a variety of blood products, including PRBC, plate-
lets, cryoprecipitate, fresh frozen plasma, and WBC’s for different
reasons and the BMT nurse must be aware of these products and
indications to use them. It is important that nurses are aware of
compatibility issues, leukocyte reduced products, irriated products,
indications for use of speciﬁc products as well as possible patient
responses to these products. It is also crucial to know the implica-
tion for BMT patients, especially in the allogeneic patients when
blood type between patient and donor may not be compatible.
Reviewing ABO and Rh compatibility information serves as a basis
for understanding the procedures and assessment that are critical
for a safe and successful transfusion. BMT patients have the added
complication of changing blood types and the BMT nurse must be
aware of this time period to deliver the safest product. Items to be
reviewed include ABO and RH typing, ABO compatibility, signs
and symptoms of transfusion reaction as well as delayed reaction,
irradiation, leukocyte reduction, donor issues, implications of
transfusion for BMT patients, and nursing care and assessment of
transfusions. An article with CEU credit will also be distributed.
Most often the care of a patient receiving a transfusion is routine
and uneventful. However, a great deal of knowledge is required
before a nurse can understand aspects of transfusion therapy and
intervene when a reaction does occur. Consistent high level nurs-
ing assessment and skills are paramount to knowing how and when
to intervene.
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NURSING MANAGEMENT OF PATIENT WITH HEMORRHAGIC CYSTITIS
POST BMT
Dela Cruz, B.P. MD Anderson Cancer Center, Houston, TX
Hemorrhagic cystitis is a syndrome of hematuria with symptoms
of urinary tract irritability indicated by dysuria, frequency and
urgency. Incidence varies according to conditioning regimen, pre-
ventative measures employed, and graft versus host disease pro-
phylaxis used. There are two types of occurrences: 1. Early onset
happens during or shortly after the conditioning regimen in which
patients may have received cyclophosphamide, ifosphamide or
busulfan. 2. Late onset occurs weeks to months after bone marrow
transplant related to contraction of certain viruses.
BMT patient who are immunocompromised, viruses are reacti-
vated and excreted in the urine. In general viral shredding occurs
2-8 weeks after BMT and resolves spontaneously within three
weeks. Another risk factor that contributes to hemorrhagic cystitis
is GVHD. The bladder epithelium is a target organ for GVHD to
attack and immunosuppressed patients already having associated
complications with GVHD have an increased risk for acquiring
viral infections.
Standard treatment modalities of hemorrhagic cystitis are: 1.
Hydrating patients with intravenous and oral ﬂuids. 2. Continuous
bladder irrigation. 3. Bladder Instillation with Alum, Carboprost,
silver nitrate, phenol, prostaglandin, and hydrocortisone. 4. Giving
smooth muscle relaxants for bladder spasms. 5. Antiviral therapy. 6.
Cystoscopy. 7. Our center is studying NOVO-seven injections to
help with the clotting mechanism.
The nurses have an essential role in early detection. Mnemonics
that would assist nurses in patient assessment is “U PAAS BI.”
U-urinary output, P-pain management, A–assessment of urine,
S–specimen collection for urine cytology, B–blood counts and
I-infusion of blood products as necessary.
Chemotherapy and viruses may account for a substantial propor-
tion of late onset and long lasting hemorrhagic cystitis in BMT
patients. In conclusion, nursing plays a huge role in prevention,
early detection and treatment of hemorrhagic cystitis.
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THERAPEUTIC MILESTONE OF DONOR LYMPHOCYTE INFUSION
Austria, M.L.R., Ramirez, M.P.T. MD Anderson Cancer Center,
Houston, TX
Since early 1990, several studies cited that transfusion of donor
lymphocytes is effective in inducing remission in patients with
relapsed hematologic malignancies after allogeneic stem cell trans-
plant. The procedure requires the leukocyte donor, which in most
cases is the original donor to undergo leukopheresis. The lympho-
cytes are then infused into the patient either immediately or after
it has been frozen. Such treatment attempts the donor’s lympho-
cytes to seek out the patient’s cancer cells and eventually destroy
them without the need for further high-dose chemotherapy or
second transplant. This beneﬁcial effect is called graft-versus-
malignancy effect.
Donor lymphocyte infusion (DLI) is used for various malignan-
cies. The majority of Chronic Myelogenous Leukemia (CML)
patients have impressive outcomes but less effective in acute leu-
kemias, myelodysplasia, multiple myeloma, Hodgkin’s disease, and
non-Hodgkin’s lymphoma. In addition, the presence of chronic
graft-versus-host disease (GVHD) after initial bone marrow trans-
plant, T-cell depletion, underlying disease and stage at relapse, and
the level of mixed chimerism inﬂuence the response rate. It works
effectively at the stage of minimum residual disease (MRD) and
should be used at the ﬁrst signs of disease recurrence (Sladen, S.).
The main causes of morbidity and treatment-related toxicities
include GVHD and bone marrow aplasia, with increased im-
munosuppression and susceptibility to opportunistic infections.
Continued research is ongoing to determine the long-term ef-
fectiveness of DLI, minimizing its side effects and the induction of
graft versus malignancy effect.
Response rate of various malignancies from DLI and a case study
will be presented.
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DEVELOPMENT OF A TRANSPLANT EDUCATIONAL PROGRAM THAT
PROVIDES CONSISTANT EDUCATION, IS AVAILABLE ON-DEMAND, AND
IS EASY TO UPDATE
Kruse, S.M., Schmit-Pokorny, K. University of Nebraska Medical Cen-
ter, Omaha, NE
Development of a professional patient education tool that pro-
vides consistent education but is easy to update has been difﬁcult
for blood and marrow stem cell transplantation (BMSCT). Many
videos exist that have been developed at a high cost. However,
videos out-date very quickly and it is impossible to ensure each
patient has the most current copy of the information.
For many years at our transplant center, the initial educational
session was 1:1 with the patient and family. The sessions provided
information on the basics of BMSCT and lasted 2-3 hours. Due to
duplication of nursing effort and lack of consistent information, a
class for BMSCT was developed in 1995. The nurse case managers
would rotate teaching the class that consisted of a slide show
presentation and an outline. There were variations and inconsis-
tencies in the information given depending on the nurses’ area of
expertise and their teaching abilities.
In 2003, a 40-minute multimedia presentation, consisting of
scripted audio speciﬁc to each corresponding visual media, and
streaming video was developed. This presentation is available to
patients and family on a ‘video on-demand service’ available in all
transplant patient suites, treatment center rooms, and other patient
care areas. The patient or caregiver can view the presentation 24
hours a day at their convenience. Over a period of seven months,
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